Lumexa Imaging Achieves Record De Novo Expansion in 2025
Rhea-AI Summary
Lumexa Imaging (NASDAQ: LMRI) set a company record by opening nine de novo outpatient imaging centers in 2025, including two centers that opened in December in Anderson, South Carolina and Cotswold, North Carolina. With these additions, Lumexa operates more than 185 centers across 13 states. Prior 2025 openings occurred in New York, South Carolina and Texas. Management said the de novo strategy targets high-growth MSAs and intends to continue expansion in 2026.
Positive
- Opened 9 de novo centers in 2025
- Now operates more than 185 centers across 13 states
- Expanded into Anderson, SC and Cotswold, NC in December
- Growth focused on high-growth MSAs to increase access
Negative
- None.
News Market Reaction – LMRI
In the Jan 8 session, LMRI gained 2.49%, reflecting a moderate positive market reaction. Argus tracked a trough of -3.4% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 05 | Conference participation | Neutral | +3.3% | Management announced plans to present at a major healthcare investor conference. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Limited history: one recent neutral conference update was followed by a modest positive price reaction.
Over the past month, Lumexa Imaging completed its IPO, put long-term debt facilities in place, and then began trading with a market cap near $1.64B. The first tracked post-IPO news, participation in the J.P. Morgan Healthcare Conference on Jan 12, 2026, saw shares rise about 3.33%. Today’s announcement of record de novo center openings in 2025 continues the theme of growth and footprint expansion following the IPO and balance-sheet restructuring.
Key Terms
restricted stock units financial
volume weighted average price financial
term loan facility financial
revolving credit facility financial
initial public offering regulatory
stock option financial
lock-up regulatory
covenant financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company opens nine new outpatient imaging centers, expanding access to high-quality, cost-effective care
"Our consistent success executing on our de novo strategy, including a record year in 2025, is a testament to our team's commitment and the value we deliver to patients and stockholders alike," said Caitlin Zulla, CEO of Lumexa Imaging. "Improving the lives of our patients is what drives us to strategically expand access to high-quality imaging through elevated, compassionate care. In 2026, we aspire to continue advancing healthcare across the country through opening more de novos both independently and with our joint venture partners."
With an aging population and an increase in both chronic and complex conditions, freestanding outpatient imaging centers like those operated by Lumexa Imaging play a critical role in providing accessible high-quality care. With extended hours and easily accessible retail locations in some of the fastest growing metropolitan statistical areas (MSAs) of the country, Lumexa Imaging's centers make it easy for patients to complete imaging exams, including MRIs, CTs, and PET/CTs, that help diagnose disease and guide appropriate treatment – typically at a lower cost compared to hospital-based alternatives.
"Lumexa Imaging's de novo growth strategy is focused on high-growth MSAs" said Lumexa Imaging Chief Growth Officer Chris Core. "Through this targeted strategy, Lumexa Imaging has built the second largest footprint of outpatient imaging centers in the nation, and we intend to continue that momentum in 2026 as we deliver continued growth for all of our stakeholders."
About Lumexa Imaging
Lumexa Imaging (NASDAQ: LMRI) is a nationwide provider of outpatient medical imaging. With over 5,000 team members and more than 185 outpatient imaging centers across 13 states, our team conducted approximately 4 million outpatient scans in 2024. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact contained in this press release, including statements regarding our future openings of de novo centers, business strategy and plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as "may," "would," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, results of operations, liquidity and stock price. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements.
Forward-looking statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein.
Media Contact
Melissa
corpcomms@lumexaimaging.com
IR Contact
IR@lumexaimaging.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lumexa-imaging-achieves-record-de-novo-expansion-in-2025-302655934.html
SOURCE Lumexa Imaging